Randomized, Double-Blind Placebo-Controlled Multi-Center Proof-of-Concept Study to Assess the Efficacy of AIN457 in Patients With Psoriatic Arthritis
Phase of Trial: Phase II
Latest Information Update: 17 Nov 2015
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriatic arthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors Novartis
- 09 Nov 2011 Results for the parent study presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 02 Feb 2011 New source identified and integrated (United Kingdom Clinical Research Network).
- 07 Apr 2009 Actual initiation date (Mar 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History